Korean J Dermatol.
2004 May;42(5):665-668.
A Case of Paronychia, Acneiform Eruption and Dry Skin Induced by Iressa(R)
- Affiliations
-
- 1Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. knderma@cmc.cuk.ac.kr
Abstract
- Iressa(R) (ZD1839) is a new anticancer agent, acting as a selective epidermal growth factor receptor tyrosine kinase inhibitor. Iressa(R) has been generally well-tolerated in cancer patients. Predominant adverse effects are an acne-like skin rash, diarrhea, nausea, vomiting, dry skin, and mild to moderate myelosuppression. The side effect of paronychia or alopecia is rare. We report a case of paronychia with granulation tissue induced by Iressa(R). Our patient complained of an acneiform eruption on his face and xerosis on his left arm and both feet as well as paronychia of several finger and toe nails.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa(R))
- A Case of Acneiform Skin Eruption Associated with ZD1839(Iressa(R))
- Two Cases of Acneiform Eruption Caused by Epidermal Growth Factor Receptor Inhibitors
- A Case of Acneiform Eruption and Paronychia Occurring after Use of Erlotinib (Tarceva(R))
- Study of Clinical Features of Cutaneous Side Effects Associated with ZD 1839
